Arecor Therapeutics PLC (AREC) — Cash Flow Quality Index
Arecor Therapeutics PLC (AREC) has a Cash Flow Quality Index of -0.33x as of December 2025. Operating cash flow of GBX-1.15 Million is below net income of GBX3.44 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore AREC cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Arecor Therapeutics PLC Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Arecor Therapeutics PLC across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Arecor Therapeutics PLC to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Quality Index for Arecor Therapeutics PLC (2025–2025)
Year-by-year earnings quality comparison for Arecor Therapeutics PLC. For live market cap and the full company financial profile, see Arecor Therapeutics PLC market cap and net worth.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -2.46x | GBX-2.29 Million | GBX932.00K | — |